Protara Therapeutics Inc. (NASDAQ: TARA) Stock Information | RedChip

Protara Therapeutics Inc. (NASDAQ: TARA) Listen to this Section


$2.07
+0.0150 ( +0.73% ) 186.9K

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Market Data


Open


$2.07

Previous close


$2.05

Volume


186.9K

Market cap


$41.47M

Day range


$2.00 - $2.12

52 week range


$1.04 - $5.24

Insider Ownership Transactions

Total Amount Purchased: -110,284.00 | $ -227,736.46

Date Type Amount Purchased Purchaser
2024-07-18 Sale -7896.00 Opaleye Management Inc.
2024-07-11 Sale -5997.00 Opaleye Management Inc.
2024-07-03 Sale -5788.00 Opaleye Management Inc.
2024-06-28 Sale -34103.00 Opaleye Management Inc.
2024-06-27 Sale -6500.00 Opaleye Management Inc.
2024-06-10 Sale -10000.00 Huang Jane
2024-06-10 Sale -10000.00 Levy Richard S
2024-06-10 Sale -10000.00 SARGEN GREGORY
2024-06-10 Sale -10000.00 GARCEAU ROGER
2024-06-10 Sale -10000.00 Smith Cynthia

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Aug 06, 2024
10-q Quarterly Reports 75 Aug 06, 2024
4 Insider transactions 1 Jul 18, 2024
4 Insider transactions 1 Jul 11, 2024
4 Insider transactions 1 Jul 03, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 1 Jun 10, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.